Natural history and staging of prostate cancer
- PMID: 6375067
Natural history and staging of prostate cancer
Abstract
The natural history and staging of prostatic cancer, directly or indirectly, involve natural expectancy of the host, malignant potential of the tumor, extent of the tumor, and response of the tumor to treatment. Discussion of these topics is followed by a description of the systems of clinical staging of the disease.
Similar articles
-
Incidental carcinoma of the prostate: histopathology and natural history.Jpn J Clin Oncol. 1985 Dec;15(4):619-23. Jpn J Clin Oncol. 1985. PMID: 2419598
-
[Morphological factors in the prognosis of the treatment results in prostatic cancer].Urol Nefrol (Mosk). 1996 Jan-Feb;(1):22-5. Urol Nefrol (Mosk). 1996. PMID: 8659037 Clinical Trial. Russian.
-
Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.J Clin Oncol. 2004 Mar 1;22(5):957-8. doi: 10.1200/JCO.2004.05.054. J Clin Oncol. 2004. PMID: 14990654 No abstract available.
-
Management of newly diagnosed metastatic carcinoma of the prostate.Urol Clin North Am. 1984 May;11(2):283-95. Urol Clin North Am. 1984. PMID: 6428022 Review.
-
Prostate cancer: 2. Natural history.CMAJ. 1998 Sep 22;159(6):685-91. CMAJ. 1998. PMID: 9780970 Free PMC article. Review. No abstract available.
Cited by
-
Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.Histochem J. 1995 Mar;27(3):196-203. Histochem J. 1995. PMID: 7797424
-
AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage, and DNA content.Clin Mol Pathol. 1996 Aug;49(4):M209-13. doi: 10.1136/mp.49.4.m209. Clin Mol Pathol. 1996. PMID: 16696076 Free PMC article.
-
Differential expression of matrix metalloproteinase-2 expression in disseminated tumor cells and micrometastasis in bone marrow of patients with nonmetastatic and metastatic prostate cancer: theoretical considerations and clinical implications-an immunocytochemical study.Bone Marrow Res. 2012;2012:259351. doi: 10.1155/2012/259351. Epub 2012 Nov 26. Bone Marrow Res. 2012. PMID: 23227342 Free PMC article.
-
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes.J Clin Invest. 2004 Dec;114(12):1774-81. doi: 10.1172/JCI22284. J Clin Invest. 2004. PMID: 15599402 Free PMC article.
-
Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.Clin Pharmacokinet. 1998 May;34(5):405-17. doi: 10.2165/00003088-199834050-00005. Clin Pharmacokinet. 1998. PMID: 9592622 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical